Martin Savage is Emeritus Professor of Paediatric Endocrinology at William Harvey Research Institute, Barts and the London School of Medicine & Dentistry, Queen Mary, University of London. He was head of the Paediatric Endocrine Unit at Barts and the London School of Medicine from 1982 to 2007. He has interests in growth disorders, specifically those with abnormalities in the GH-IGF-1 axis and in phenotype-genotype relationships of GH-IGF-1 axis defects, notably GH resistance. He published the first human case of an IGF-1 gene defect in the New England Journal of Medicine in 1996. His other interests are Cushing’s syndrome and growth in chronic inflammatory diseases. He was General Secretary of the European Society for Paediatric Endocrinology (ESPE) from 1997 to 2004. He has lectured in 61 countries and has published 472 original articles, reviews, textbook chapters and books. In 2007, he was awarded the ESPE Andrea Prader Prize for contributions to paediatric endocrinology and in 2018 he received a Visionary Award from the American Human Growth Foundation. In 2022, he received a Research Excellence Award from the Dr Sulaiman Al Habib Medical Journal in Riyadh, and the British Society of Paediatric Endocrinology & Diabetes James M. Tanner Lifetime Achievement Award. He continues to lecture nationally and internationally.
Bernadette Biondi is Full Professor of Internal Medicine at the University of Naples Federico II Medical School, Italy, where she teaches cardiovascular endocrinology and researches clinical thyroidology, with a special focus on subclinical thyroid dysfunction. She has recently been member of the Awards Committee Roster of the American Thyroid Association and chaired the European Thyroid Association’s task force for the development of clinical practice guidelines for the diagnosis and treatment of subclinical hyperthyroidism in 2015. She is also member of the editorial board of important scientific journals such as Clinical Thyroidology and Frontiers in Thyroid Endocrinology. Professor Biondi is author and co-author of numerous papers published in journals including the American Journal of Medicine, Annals of Internal Medicine, Circulation, Endocrine Reviews, The European Heart Journal, The European Journal of Endocrinology, Endocrinology Metabolic Clinics of North America, Journals of the American College of Cardiology, The Journal of Clinical Endocrinology and Metabolism, JAMA, Lancet, The New England Journal of Medicine and Thyroid.
Gabriela Brenta, M.D., Ph.D., is an Assistant Professor at the Medical School of the University of Buenos Aires and a staff member of the Department of Endocrinology and Metabolism at Dr. Cesar Milstein Care Unit in Buenos Aires, where she coordinates the Thyroid Unit.
In June 2019, Dr. Brenta ended her term as President of the Latin American Thyroid Society (LATS), and in 2020 was engaged on behalf of LATS in the Scientific Committee of the 16th International Thyroid Congress and also in the Scientific Committee of the 19th International Congress of Endocrinology.
In 2022 she was included in the Scientific Committee of LATS Congress 2023 Curitiba, Brazil, and the Task Force of the American Thyroid Association Thyroid and Pregnancy Guidelines.
Dr. Brenta is also a member of the Argentine Society of Endocrinology and Metabolism (SAEM) with active participation in its Thyroid Department. Her areas of interest in clinical research include the cardiovascular and metabolic effects of thyroid hormones and the study of thyroid diseases, including nodular disease, in older adults. Original papers and reviews have been published in Thyroid, Nature, and JCEM. She is also a member of the editorial board of Thyroid and Journal of Endocrinology Investigation.
Antonio Ceriello is currently an award-winning research consultant at Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS) MultiMedica, Milan, Italy. He has worked internationally both clinically and in research.
His research interests are centred around cardiovascular disease and diabetes. He was a consultant with the National Institute of Health (NIH), in the US from 2003–2005, and a member of the writing committee for the American Heart Association Guidelines on Acute Hyperglycemia and Acute Coronary Syndromes. He has been instrumental in both the development (2008) and the update (2011) of the International Diabetes Federation (IDF) Committee Guidelines for Management of Post-meal Glucose. Currently, he is the Chairman of the Diabetes and Cardiovascular Diseases Study Group of the European Association for the Study of Diabetes (EASD). Professor Ceriello has been involved with numerous guidelines including the European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (2012), European Society of Cardiology (ESC) Guidelines on Diabetes, Pre-diabetes, and Cardiovascular Diseases developed in collaboration with the EASD (2013 and 2019), and the Continuous Glucose Monitoring Metrics for Clinical Trials International Consensus developed by the ADA, ADCES, EASD, ISPAD, JDS, JDRF and endorsed by the FDA and EMA (2022). He has been appointed by IDF as Co-Chairman for the development of the 2023 Guidelines for the Management of Type 2 Diabetes in Different Settings and as Chairman for the 2024 IDF Global Meeting. He is also currently the IDF representative for global action for developing a research and action roadmap for fatty liver disease, as well as developing the IDF-ISN policy brief on diabetic nephropathy (in co-operation with WHO) and the obesity cinical practice recommendation and education project (in cooperation with WOF).
Professor Ceriello has published over 500 original papers and several book chapters. His current h-index is 119 (Google Scholar). He served as Associate Editor of Diabetes Care (2003–2011) and Diabetic Medicine (2005–2016). Currently he is Editor-in-Chief of Diabetes Research and Clinical Practice, the official IDF journal (current IF 8.18) and serves on the editorial board of Cardiovascular Diabetology.
Dr Ernesto Maddaloni, is currently Assistant Professor of Endocrinology and Diabetes at Sapienza University of Rome, Italy. He gained his MD, clinical specialty in Endocrinology and Diabetes and PhD in “Integrated Biomedical Sciences and Bioethics” at Campus Bio-Medico University of Rome. He has joined the Vascular Cell Biology Section of the Joslin Diabetes Center (Harvard Medical School) for a Post-Doctoral Research Fellowship in 2014 and the Diabetes Trial Unit of the University of Oxford in 2017 as a mentee of the European Foundation for the Study of Diabetes (EFSD) Future Leaders Mentorship Program, to actively pursuing his studies on clinical diabetes, cardiovascular outcomes and novel diabetes complications. His research interests focus on the study of adults with autoimmune diabetes and the interplay between vascular complications, bone health and autoimmunity. After the Sars-CoV2 infection outbreak, he has contributed also with original articles evaluating the strict relationship between diabetes and related comorbidities with Covid-19. Dr Maddaloni has been a study investigator and coordinator for several national and international clinical trials and has published as lead author in several top-ranked peer-reviewed international medical journals.
His scientific achievements have been recognized with several awards, including the 2015 Albert Renold Fellowship from the European Foundation for the Study of Diabetes, the 2017 (under 32) and 2021 (under 35) Young Investigator Awards from the Italian Society of Endocrinology (SIE), the 2017 Early Investigator Award from the Endocrine Society (USA) and the 2020 Young (under 35) Investigator Award from the Italian Society of Diabetes (SID).
Currently serving as Professor of the Department of Biochemistry and Molecular Biology at the University of the Philippines College of Medicine, and a Clinical Professor at the Division of Endocrinology, Diabetes and Metabolism of the Department of Medicine at the Philippine General Hospital, Dr Nemencio Nicodemus Jr. is also Vice Chair for Postgraduate Training and the departmental training officer. Nationally, Prof. Nicodemus is the Treasurer of the Philippine College of Physicians, President of the Philippine Association for the Study of Overweight and Obesity (PASOO) and a past President of the Philippine Thyroid Association and the Philippine Society of Endocrinology, Diabetes and Metabolism. An active and engaging lecturer, Dr Nicodemus has been invited to several regional and international conferences, including the International Society of Endocrinology, International Diabetes Federation and ASEAN Federation of Endocrine Societies as a resource speaker. Prof. Nicodemus has published several articles and book chapters on diabetes, thyroid and obesity. He is a member of the technical committee who oversee clinical practice guidelines on diabetes in pregnancy and thyroid disorders in pregnancy, including guidelines on recurrent pregnancy loss in the Philippines.
Dr Salman Razvi is a Senior Lecturer in Endocrinology at Newcastle University, and Consultant Endocrinologist and Director of Research and Development at Queen Elizabeth Hospital NHS Trust, Gateshead, UK. His research interests centre around the action of thyroid hormones, particularly on the cardiovascular system. He is the chief investigator of several projects funded by various statutory funding bodies and charities, and is a member of the editorial board of Thyroid, the Journal of Clinical Endocrinology and Metabolism, Frontiers in Endocrinology and the Journal of Endocrinological Investigations. He has more than 90 peer-reviewed publications and book chapters, mainly relating to thyroid dysfunction. In addition, Dr Razvi is a member of the executive committee of the British Thyroid Association and the medical advisor to the patient-led charity, the British Thyroid Foundation.
Guillermo Umpierrez is a Professor of Medicine in the Division of Endocrinology at Emory University School of Medicine in Atlanta, Georgia, and the 2022 President of the American Diabetes Association (ADA).
He is a clinician, scientist and educator who has received numerous teaching awards for Best Clinical Teacher and Mentor at Emory University, and national awards from the American College of Physicians, American Association of Clinical Endocrinologists, Diabetes technology Society, Endocrine Society and the American Diabetes Association.
His research interests include mechanisms for beta-cell dysfunction in minority populations, prevention of acute and chronic diabetic complications, and hospital management of patients with diabetes and hyperglycemia. He is the author of more than 450 scientific manuscripts and book chapters, and has presented over 400 research abstracts at national and international scientific meetings. He is also the director of the Emory Latino Diabetes Education Program, a nationally accredited Spanish Diabetes education program dedicated to providing diabetes education to Latinos.
